Annual Stockholders’ Meeting 2017

Dr. Norbert W. Bischofberger

Dr. Norbert W. Bischofberger

Executive Vice President Research & Development and Chief Scientific Officer of Gilead Sciences Inc.

January 10, 1956

born in Mellau, Austria

1975 – 1980

Studies of chemistry at Leopold-Franzens-University, Innsbruck, Austria

1980 – 1983

Doctorate (Dr. rer. nat.) at the Eidgenössische Technische Hochschule Zurich, Switzerland

1983 – 1984

Postdoc at Syntex Inc., Palo Alto, California, USA

1984 – 1986

Postdoc at Harvard University, Cambridge, Massachusetts, USA

1986 – 1990

Scientist in the Molecular Biology Department at Genentech Inc., South San Francisco, California, USA, from 1988 Manager DNA synthesis

Since 1990

Gilead Sciences Inc., Foster City, California, USA

1990 – 1993

Director Organic Chemistry

1993 – 1995

Vice President Organic Chemistry

1995 – 1997

Vice President Research

1997 – 1999

Senior Vice President Research

1999 – 2007

Senior Vice President Research and Development

Since 2007

Executive Vice President Research & Development and Chief Scientific Officer

Membership of statutory supervisory boards:

  • None


Membership of comparable control bodies of corporations in Germany or abroad:

  • InCarda Therapeutics Inc., Brisbane, California, USA (Member of the Board of Directors, since 2016)